Cellular and humoral immune responses to adenovirus and p53 protein antigens in patients following intratumoral injection of an adenovirus vector expressing wild-type. P53 (Ad-p53).
Yen N, Ioannides CG, Xu K, Swisher SG, Lawrence DD, Kemp BL, El-Naggar AK, Cristiano RJ, Fang B, Glisson BS, Hong WK, Khuri FR, Kurie JM, Lee JJ, Lee JS, Merritt JA, Mukhopadhyay T, Nesbitt JC, Nguyen D, Perez-Soler R, Pisters KM, Putnam JB Jr, Schrump DS, Shin DM, Walsh GL, Roth JA.
Yen N, et al.
Cancer Gene Ther. 2000 Apr;7(4):530-6. doi: 10.1038/sj.cgt.7700138.
Cancer Gene Ther. 2000.
PMID: 10811470
Clinical Trial.